| FASMX | RLBEX | FASMX / RLBEX | |
| Total Expense Ratio | 0.53 | 0.59 | 90% |
| Annual Report Gross Expense Ratio | 0.56 | 0.59 | 95% |
| Fund Existence | 37 years | 24 years | - |
| Gain YTD | 2.612 | 2.459 | 106% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 10.6B | 270B | 4% |
| Annual Yield % from dividends | 2.31 | 1.87 | 123% |
| Returns for 1 year | 10.51 | 11.32 | 93% |
| Returns for 3 years | 28.30 | 36.71 | 77% |
| Returns for 5 years | 17.37 | 35.56 | 49% |
| Returns for 10 years | 71.06 | 90.55 | 78% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HRMDX | 14.24 | 0.21 | +1.50% |
| Heartland Mid Cap Value Investor | |||
| BDSCX | 20.22 | 0.04 | +0.20% |
| BlackRock Advantage Small Cap Core Inv C | |||
| RYOIX | 77.25 | -0.11 | -0.14% |
| Rydex Biotechnology Inv | |||
| VRTGX | 471.00 | -1.06 | -0.22% |
| Vanguard Russell 2000 Growth Index I | |||
| RFNGX | 94.71 | -1.14 | -1.19% |
| American Funds Fundamental Invs R6 | |||